Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sinovac Provides Update on Study of Third Dose of Its Pandemic Influenza Vaccine 2007-03-06 21:00
Natural Health Trends Corp. Stockholders Filed a Schedule 13-D/A 2007-03-02 16:42
Phase II Cystic Fibrosis Study Closes Enrollment 2007-03-01 21:35
Mindray to Present at Lehman Brothers 10th Annual Global Healthcare Conference 2007-03-01 21:00
Fourth Phase III Study of Vandetanib (ZACTIMA(TM), ZD6474) in Patients With Advanced Lung Cancer 2007-02-26 22:00
ScinoPharm's 2006 Revenue and Net Income at Record High 2007-02-26 21:00
Elsevier Announces Its Point-Of-Care Medical Information to Be Offered as Part of Chinese Electronic Health Record 2007-02-26 21:00
Lilly Plans New Clinical Trial of Xigris(R) 2007-02-26 19:00
Sinovac Attended 3rd WHO Meeting on Evaluation of Pandemic Influenza Prototype Vaccines in Clinical Trials 2007-02-20 21:00
Medical Group Inc. to Present at the Roth Capital Partners 19th Annual OC Conference 2007-02-20 21:30
Mindray to Exhibit Latest Ultrasound System at 2007 European Congress of Radiology 2007-02-16 21:00
Mindray to Report Fourth Quarter and Fiscal Year 2006 Financial Results on March 12, 2007 2007-02-16 21:00
Mindray Medical Receives Frost & Sullivan 2006 Global Market Penetration Leadership Award in the Patient Monitoring Market 2007-02-16 21:00
TaiGen Appoints Dr. Luke Lin VP of Clinical Research & Development 2007-02-14 22:00
Winner Medical Group Reports First Quarter Fiscal 2007 Results 2007-02-14 21:30
WuXi PharmaTech CEO Honored with 2006 China Top Ten Talents (Science & Technology) Award 2007-02-13 18:30
China Health Holding Appoints Mr. Yu, XiaoFei as President 2007-02-12 23:08
StemCore is First Independent Review Board Specializing in Stem Cell Research Protocols 2007-02-12 09:00
Sinovac Files Registration Documents for Euvax-B(TM) with SFDA Loan Repayment Received from One Former Director 2007-02-08 21:00
China Pharma Announces Successful Private Placement of $3.85 Million 2007-02-06 21:00
1 805 806 807 808 809 812